Biomarkers 2024, designed to provide forward-looking insights into the latest trends and tools impacting biomarker research, it brings together leading experts from global pharmaceutical organisations, innovative biotech companies and internationally renowned academic institutions working across multiple therapeutic areas and stages of drug development.
Topics: biomarkers, oncology, clinical development, neuroscience, NASH, biomarker technologies, digital pathologies